Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109

9518447302
|
Calling
Whatsapp
Get in touch
Download Visual

High-resolution images and Product visuals

Watch Video

Product overview and usage information

Read Literature

Detailed information and research documents

About the Product

Description

Restripe 80 Tablet contains Resmetirom 80mg, a high-potency therapy for lipid and liver health management. It effectively reduces liver fat, improves lipid metabolism, and supports liver function, making it ideal for patients with NAFLD and metabolic disorders.

Prescribers trust this tablet for its clinical efficacy and safety, providing patients with consistent liver and metabolic health benefits. Improved outcomes lead to better adherence and repeat prescriptions, ensuring steady demand.

For franchise partners, Restripe 80 Tablet is a premium product in the liver and metabolic care segment, offering strong market potential. Its advanced therapeutic profile and prescriber confidence make it a profitable addition to specialty portfolios, enhancing business reach.

With the rising prevalence of NAFLD and lipid-related disorders, Restripe 80 Tablet provides sustainable sales opportunities, helping partners establish a strong presence in the liver and metabolic care segment.

Common side effects may include headache, fatigue, nausea, diarrhea, or mild transient increases in liver enzymes. Some patients may experience palpitations, insomnia, or gastrointestinal discomfort. Severe or persistent symptoms should be reported immediately to a healthcare professional.

Restripe 80 Tablet is indicated for the treatment of non-alcoholic steatohepatitis (NASH) and associated dyslipidemia in adults. It helps reduce liver fat content, improve lipid metabolism, and support liver function in patients at risk of progressive liver disease.

Restripe 80 Tablet should be taken as prescribed and not used in patients with severe liver dysfunction or hypersensitivity to Resmetirom. Regular monitoring of liver function tests and lipid profile is recommended during therapy. Inform your doctor about other medications or underlying health conditions before starting treatment.

Store Restripe 80 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date indicated on the pack.

Get in Touch

Similar Products

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Resmetirom 80mg Tablet in the PCD pharma franchise market?

Resmetirom 80mg Tablet has strong emerging demand in the specialty hepatology and metabolic liver disease segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on liver care and chronic metabolic disorder portfolios.

Why should medical distributors include Resmetirom 80mg Tablet in their product range?

Medical distributors and agencies can benefit from increasing clinical focus on non-alcoholic steatohepatitis (NASH) and metabolic dysfunction-associated steatotic liver disease (MASLD/MAFLD) under specialist supervision. Resmetirom 80mg is a thyroid hormone receptor-beta (THR-β) agonist Helps reduce liver fat accumulation and improves metabolic liver function Used in specialist hepatology and metabolic disease management protocols This strengthens a niche but high-value specialty liver-care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Resmetirom 80mg Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Resmetirom 80mg Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from growing demand in hepatology clinics, emerging NAFLD/NASH treatment market, long-term chronic therapy usage, hospital prescriptions, reliable supply chain support, and strong margins in specialty liver medicines.

How can I become a distributor or franchise partner for Resmetirom 80mg Tablet?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.

Our Manufacturing Partners

Our Manufacturing Partner | Akums Drugs and Pharmaceuticals
Our Manufacturing Partner | Pharmaceuticals Pvt. Ltd.
Our Manufacturing Partner | Tirupati
Our Manufacturing Partner | Swess-Garniers
Our Manufacturing Partner | Windlas Biotech Limited
Our Manufacturing Partner | Hetero Pharmaceutical company
Our Manufacturing Partner | Unimarck
Our Manufacturing Partner | mascort
Our Manufacturing Partner | Synokem Pharmaceuticals Limited
Our Manufacturing Partner | Biodeal Pharmaceuticals Limited

Links

Contact Us

+91 9518447302
info@cafoli.in
Plot No. 367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109

Let's Socialize

Professional B2B Disclaimer: This website is a Business-to-Business (B2B) platform intended exclusively for pharmaceutical traders, distributors, wholesalers, and healthcare professionals. The information provided—including product compositions, therapeutic categories, and portfolios—is for commercial and educational reference only. It is not intended for consumers or as a substitute for professional medical advice, diagnosis, or treatment. Cafoli Lifecare does not sell medicines directly to individuals. All trade inquiries are subject to valid drug license verification.

@2024 | copy rights by Cafoli